These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9405685)

  • 1. p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?
    Bian J; Sun Y
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14753-8. PubMed ID: 9405685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization.
    Tan M; Bian J; Guan K; Sun Y
    Carcinogenesis; 2001 Feb; 22(2):295-300. PubMed ID: 11181451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
    Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
    Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound.
    Sun Y; Bian J; Wang Y; Jacobs C
    Oncogene; 1997 Jan; 14(4):385-93. PubMed ID: 9053835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of a consensus binding site for p53.
    el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
    Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
    Senoo M; Matsumura Y; Habu S
    Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
    Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
    Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
    Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
    Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation.
    Chin PL; Momand J; Pfeifer GP
    Oncogene; 1997 Jul; 15(1):87-99. PubMed ID: 9233781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
    Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
    DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.
    Pivonková H; Pecinka P; Cesková P; Fojta M
    FEBS J; 2006 Oct; 273(20):4693-706. PubMed ID: 16981908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63.
    Cai BH; Chao CF; Lu MH; Lin HC; Chen JY
    J Biochem; 2012 Jul; 152(1):99-110. PubMed ID: 22577164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
    Roth J; Koch P; Contente A; Dobbelstein M
    Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
    Lau LM; Nugent JK; Zhao X; Irwin MS
    Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2.
    Scherer SJ; Welter C; Zang KD; Dooley S
    Biochem Biophys Res Commun; 1996 Apr; 221(3):722-8. PubMed ID: 8630028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal protein S27L is a direct p53 target that regulates apoptosis.
    He H; Sun Y
    Oncogene; 2007 Apr; 26(19):2707-16. PubMed ID: 17057733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.